MBF Therapeutics Inc. Company Profile, Contacts & Intelligence
MBF Therapeutics Inc. Overview
MBF Therapeutics is an immunotherapeutics company focused on animal applications of its innovative T-Max™ immunotherapeutic DNA vaccine platform. In addition, there are significant translational opportunities in human health. Our T-Max platform addresses longstanding shortcomings of traditional viral vaccine technologies based primarily on killed/inactivated (KWV) whole virus or modified live/attenuated virus vaccines (MLV/AV). Killed virus vaccines have been fairly safe but not efficacious, while MLV vaccine must replicate to generate reasonable efficacy and therefore have significant safety issues for the vaccinated animal and also the herd because of chronic carriers and viral shedding. MBFT will create safe and efficacious vaccines focused on respiratory viral diseases that cause significant negative economic and social impacts. Specifically Porcine Reproductive and Respiratory Syndrome (PRRS) considered the most economically significant disease of worldwide swine production; and African Swine Fever (ASF), a highly fatal and reportable disease that has caused billions of dollars lost due to death/cull of millions of pigs and disrupted markets and trade throughout Asia, Europe, Africa and now threatens the US with an estimated cost impact of 50 billion dollars in lost trade and containment costs. T-Max Plasmid DNA Vaccine Platform MBFT’s T-Max™ DNA vaccine platform is a proprietary process from discovery to commercialization of protective vaccines that identifies clinically relevant pathogen antigens and delivers them in proprietary formulations to stimulate durable and potent T cell immune responses. Four components differentiate the platform: 1. Novel antigen selection process to identify multiple clinically relevant antigens to create cross-protective ”universal” vaccines; 2. Cloning into proprietary plasmids containing a non-antibiotic selection system; 3. One or more immunomodulators that stimulate a strong innate immune response; and 4. CaptaVa
- Website
- mbftherapeutics.com
- Industry
- Biotechnology
- Founded
- 2008
- Phone Number
- Available in AeroLeads
- Company Email
- Available in AeroLeads
MBF Therapeutics Inc. Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
MBF Therapeutics Inc. People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
MBF Therapeutics Inc. Workforce Composition
Seniority breakdown across 4 visible profiles.
Compare Similar Companies to MBF Therapeutics Inc.
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Proteon Pharmaceuticals | Biotechnology Research | 81 | View company |
| Distribuidora Medivet | Wholesale | 12 | View company |
| Agro Salud Animal | Pharmaceutical Manufacturing | 11 | View company |
| Accencio® | Software Development | 8 | View company |
| Opsidio, LLC | Biotechnology | 4 | View company |
| Emmyon, Inc. | Biotechnology Research | 3 | View company |
| ReEngage Therapeutics | Biotechnology Research | 3 | View company |
| Beluga Animal Health | Pharmaceutical Manufacturing | 2 | View company |
| Panorama Medicine | Biotechnology Research | 1 | View company |
| JDP THERAPEUTICS INC - (Acquired) | Pharmaceutical Manufacturing | Not listed | View company |